Effects of carbachol and (−)-N6-phenylisopropyladenosine on myocardial inositol phosphate content and force of contraction
Open Access
- 1 December 1990
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 101 (4) , 829-834
- https://doi.org/10.1111/j.1476-5381.1990.tb14165.x
Abstract
1 The effects of carbachol and the A1-adenosine receptor agonist (−)-N6-phenylisopropyladenosine (PIA) on force of contraction and inositol lipid metabolism were studied in electrically driven left auricles and papillary muscles isolated from guinea-pig hearts. Both carbachol and PIA (0.01–10 μm) had concentration-dependent negative inotropic effects in auricles. In papillary muscles PIA had no inotropic effect. Carbachol also had no inotropic effect at low concentrations (0.01–1 μm) but at 10–100 μm it exerted a slight positive inotropic effect. 2 In auricles and papillary muscles both carbachol and PIA concentration-dependently increased inositol trisphosphate (IP3; significant at 1 μm). Accordingly phosphatidylinositol bisphosphate (PIP2), the precursor of IP3, was reduced. All effects of carbachol and PIA were antagonized by atropine (10 μm) and 1,3-dipropyl-8-cyclopentylxanthine (DPCPX; 20 μm) respectively, indicating receptor-mediated effects. 3 In auricles the negative inotropic effects of carbachol and PIA preceded the increase in IP3. 4 In papillary muscles the increase in IP3 preceded the slight positive inotropic effect of carbachol, indicating that the M-cholinoceptor-mediated increase in IP3 and force of contraction may be related. However, PIA showed a comparable increase in IP3 but no inotropic effect, indicating a dissociation between those parameters. 5 In conclusion, in previous studies a close relation between increases in IP3 and force of contraction has been shown after α1-adrenoceptor stimulation. The present study with carbachol supports this view. However, the present data for PIA could not show such a close relationship, questioning the role of IP3 as an endogenous regulator of force of contraction.This publication has 36 references indexed in Scilit:
- Inositol phosphates and cell signallingNature, 1989
- Inositol trisphosphate, a novel second messenger for positive inotropic effects in the heart?Journal of Molecular Medicine, 1989
- Evidence for α1-Adrenoceptor-Mediated Increase of Inositol Trisphosphate in the Human HeartJournal of Cardiovascular Pharmacology, 1989
- Guaninnucleotid-bindende Proteine als membranäre Signaltransduktionskomponenten und Regulatoren enzymatischer EffektorenJournal of Molecular Medicine, 1988
- Increase in IP3 precedes α-adrenoceptor-induced increase in force of contraction in cardiac muscleEuropean Journal of Pharmacology, 1987
- Does the inositol tris/tetrakisphosphate pathway exist in rat heart?FEBS Letters, 1987
- Stimulation of phosphatidylinositol metabolism in atrial and ventricular myocytesLife Sciences, 1986
- Studies and Perspectives of Protein Kinase CScience, 1986
- Inositol trisphosphate does not release Ca2+ from permeabilized cardiac myocytes and sarcoplasmic reticulumFEBS Letters, 1985
- Inositol trisphosphate, a novel second messenger in cellular signal transductionNature, 1984